169 related articles for article (PubMed ID: 16223580)
1. Primary prevention of human papillomavirus-dependent neoplasia: no condom, no sex.
Epstein RJ
Eur J Cancer; 2005 Nov; 41(17):2595-600. PubMed ID: 16223580
[TBL] [Abstract][Full Text] [Related]
2. [What should be known for the introduction of an HPV vaccine?].
Muñoz N; Jacquard AC
Presse Med; 2008 Oct; 37(10):1377-90. PubMed ID: 18786806
[TBL] [Abstract][Full Text] [Related]
3. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.
Manhart LE; Koutsky LA
Sex Transm Dis; 2002 Nov; 29(11):725-35. PubMed ID: 12438912
[TBL] [Abstract][Full Text] [Related]
4. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
5. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy.
Jastreboff AM; Cymet T
Postgrad Med J; 2002 Apr; 78(918):225-8. PubMed ID: 11930025
[TBL] [Abstract][Full Text] [Related]
6. Prevention of human papilloma virus infection with vaccines.
Azam F; Shams-ul-Islam M
J Pak Med Assoc; 2010 Aug; 60(8):676-81. PubMed ID: 20726203
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus: clinical manifestations and prevention.
Juckett G; Hartman-Adams H
Am Fam Physician; 2010 Nov; 82(10):1209-13. PubMed ID: 21121531
[TBL] [Abstract][Full Text] [Related]
8. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
Stanley M
J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
[TBL] [Abstract][Full Text] [Related]
9. Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies.
Lam JU; Rebolj M; Dugué PA; Bonde J; von Euler-Chelpin M; Lynge E
J Med Screen; 2014 Mar; 21(1):38-50. PubMed ID: 24488594
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of a human papillomavirus type 16 vaccine.
Koutsky LA; Ault KA; Wheeler CM; Brown DR; Barr E; Alvarez FB; Chiacchierini LM; Jansen KU;
N Engl J Med; 2002 Nov; 347(21):1645-51. PubMed ID: 12444178
[TBL] [Abstract][Full Text] [Related]
11. Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers.
Thomas DB; Ray RM; Kuypers J; Kiviat N; Koetsawang A; Ashley RL; Qin Q; Koetsawang S
Am J Epidemiol; 2001 Apr; 153(8):740-8. PubMed ID: 11296145
[TBL] [Abstract][Full Text] [Related]
12. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.
Hogewoning CJ; Bleeker MC; van den Brule AJ; Voorhorst FJ; Snijders PJ; Berkhof J; Westenend PJ; Meijer CJ
Int J Cancer; 2003 Dec; 107(5):811-6. PubMed ID: 14566832
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
14. Cervical intraepithelial neoplasia, cervical cancer, and HPV.
Holly EA
Annu Rev Public Health; 1996; 17():69-84. PubMed ID: 8724216
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccines versus cervical cancer screening.
Stanley M
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):388-94. PubMed ID: 18538554
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccination for the prevention of cervical intraepithelial neoplasia.
Kahn JA
N Engl J Med; 2009 Jul; 361(3):271-8. PubMed ID: 19605832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
